Adam, Judit A. http://orcid.org/0000-0001-8899-8087
Loft, Annika
Chargari, Cyrus
Delgado Bolton, Roberto C.
Kidd, Elisabeth
Schöder, Heiko
Veit-Haibach, Patrick
Vogel, Wouter V.
Funding for this research was provided by:
Amsterdam UMC
Article History
Received: 30 August 2020
Accepted: 8 November 2020
First Online: 4 December 2020
Compliance with ethical standards
:
: Authors J.A. Adam, A. Loft, R.C. Delgado Bolton, E. Kidd, H. Schöder, and W.V. Vogel declare that they have no conflict of interest. Author C. Chargari receives personal fees from Takeda, MSD, GSK, and Elekta. He is an investigator for clinical trials sponsored by Roche and receives non-financial support for research from TherAguiX, all outside this guideline. Author P. Veit-Haibach receives IIS grants from Bayer Switzerland, Roche Pharmaceuticals, Siemens Healthineers, and GE Healthcare and speaker fees and travel support from Siemens Healthineers and GE Healthcare, all outside this guideline.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This guideline summarizes the views of the Oncology Committee of the EANM, the Oncology Task Force of the SNMMI and the Advisory Committee on Radiation Oncology Practice (ACROP) of the ESTRO. It reflects recommendations for which the EANM, SNMMI or ESTRO cannot be held responsible. The recommendations should be taken into context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions.